Skip to main content

Table 6 Standards of physiotherapy provision in inpatient care (51 centers) and outpatient care (62 centers)

From: The organisation of physiotherapy for people with multiple sclerosis across Europe: a multicentre questionnaire survey

Inpatient individual Number of centers providing the type of care Weeks/year median (IQR) Sessions/week median (IQR) Minutes/sessions median (IQR) Number of centers providing the data to compute the dosage Dosage in hours/year median (IQR)
 Europe 49 4 (8) 5 (1.2) 45 (30) 38 (78 %) 12.6 (27.5)
 East 6 4 (1) 5.5 (4.8) 52 (15) 6 (100 %) 32 (32.1)
 North 16 4 (24) 4 (1) 45 (20) 11 (69 %) 10 (1.8)
 South 20 4 (16) 5 (0.2) 45 (15) 15 (75 %) 20 (29.4)
 West 7 6 (5) 5 (4.5) 30 (5) 6 (86 %) 24.5 (19.4)
Inpatient group
 Europe 23 4 (7) 5 (5) 45 (16) 19 (83 %) 24 (30.4)
 East 3 4 (1) 6 (3.5) 45 (15) 3 (100 %) 24 (19.5)
 North 9 4 (4) 5 (5.2) 45 (5) 7 (78 %) 18 (16.4)
 South 6 4 (13) 5 (2.2) 52 (60) 5 (83 %) 36 (28.8)
 West 5 8 (21) 10 (9) 40 (15) 4 (80 %) 51.5 (67)
Inpatient autonomous
 Europe 7 4 (22) 5 (1.5) 30 (5) 5 (71 %) 6.0 (1.5)
Outpatient individual
 Europe 58 12 (36) 2 (2) 45 (20) 42 (72 %) 15 (16)
 East 7 8 (14) 2 (2.5) 45 (22) 6 (86 %) 9.8 (5.6)
 North 16 12 (30) 2 (3) 52 (15) 11 (69 %) 9 (14)
 South 25 10 (41) 2 (3) 45 (15) 18 (72 %) 23.2 (21.1)
 West 10 16 (33) 2 (0) 35 (15) 7 (70 %) 13.5 (11)
Outpatient group
 Europe 25 10 (44) 2 (2) 60 (15) 8 (32 %) 40 (30.2)
 East 0     0  
 North 9 10 (11) 2 (1) 60 (15) 2 (22 %) 71 (29)
 South 9 20 (46) 3 (3) 45 (15) 5 (56 %) 30 (25)
 West 7 10 (43) 2 (1.5) 60 (18) 1 (14 %) 150 (0)
Outpatient autonomous  
 Europe 6 45 (37) 5.5 (1.8) 38 (26) 3 (50 %) 15 (54)
  1. While all 51/62 centers providing inpatient/outpatient care gave details about frequency and timing of care, some misunderstood that the frequency in weeks should reffer to one patient and not to staff workload. Therefore, data from smaller proportion of centers could have been used for dosage computation
  2. Becuse of small number of centers prividing autonomous therapy, data are not broken down by region. Even so, estimates of session frequency have large, especially in outpatient centers, and are not very reliable
  3. Kruskal-Wallis test for the differences in dosage of therapy across regions yielded the following p-values for the inpatient individual, group, autonomous and outpatient individual, group, autonomous therapy respectively: 0.162, 0.538, 0.264, 0.077, 0.070, 0.221. Due to multiple testing the Bonferroni correction should be applied and the value 0.008 is used as threshold instead. The dosage of different types of therapies was not found as different across the regions